US 11884920
Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use
granted A61KA61K31/713A61K9/0019
Quick answer
US patent 11884920 (Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use) held by Arrowhead Pharmaceuticals, Inc. expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/713, A61K9/0019, A61P, A61P1/16